At Suisselle we are passionate about
innovative ideas, beauty and science.
PATIENT HEALTH is our FOCUS
& Reaching MEDICAL EXCELLENCE is our GOAL
The core technology was developed by intensive research in Switzerland, Canada, Russia and Japan over last decades.
Laboratoire Suisselle specializes in research, development and commercialization of innovative medical device products, such as mesotherapy and hyaluronic acid fillers for aesthetic use.
Constant improvement of processes and products
A.P.R.I. technology is a patented ecollogically safe method of crosslinking HA molecules in one phase. A.P.R.I. technology ensures effective crosslinking & modification of HA.
This became possible thanks to years of research done by Suisselle laboratory in the field of synthetizing cross-linked HA salts in super concentrated aqueous solution
Stringent testing of our products
for maximum effectiveness and sustainability
THE HIGHEST STANDARDS
- High Quality Biosynthetic Hyaluronic Acid
- Biocompatible in compliance with ISO 10993 international standards: Non cytotoxic – Non irritant – Non sensitizing – Non mutagenic
- Proved efficiency thanks to in vitro studies confirmed by clinical records